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Abstract:
Unconjugated bilirubin (UCB) is produced mostly in the spleen from the
turnover of heme. UCB is conjugated by the activity of hepatic UGT1A1enzyme
(UDP-glucuronosyltransferase 1A1) and exported into the bile. High serum level
of UCB is toxic to cells, and its intracellular accumulation is suggested to be
limited by multidrug resistance proteins 1 and 3 (MRP1 and MRP3) that export
UCB out of the cells to prevent its toxicity. In this study, the expression profile
for MRP1 and MRP3 was analysed by qRT-PCR and Western blot in the liver
and the spleen of two animal models of hyperbilirubinemia (β-thalassemic mouse
and Gunn rat). The results indicated that MRP1 mRNA and protein expression
remained unchanged in the liver and spleen of both animal models. MRP3
mRNA and protein are up-regulated in the spleen of β-thalassemic mouse and
liver of Gunn rat. In conclusion, high level of UCB induces only the expression
of MRP3 which may indicate its possible role in preventing UCB toxicity.
Keywords: Multidrug resistance-associated proteins, hyperbilirubinemia, βthalassemia, Gunn rat.
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الملخص:
البيليروبين غير المباشر هي مادة صفراء اللون تنتج عن تكسير جزيء الهيم الموجود في الهيموغلوبين
المك ِّون لكريات ال ّدم الحمراء في الطحال ،نتيجة نشاط إنزيمان هما(Heme oxygense I and :
) ،Biliverdin reductaseنظرا وألن مادة البيليروبين غير المباشر هي مادة غير ذائبة في الماء ،فإنها
تنتقل إلى الكبد وتتّحد مع حمض ) (Glucurionic acidبواسطة اإلنزيم ) ،(UGT1A1وهكذا يتحوّل
الى البيليروبين المباشر الذائب في الماء ،والذي يتخلّص منه الجسم عن طريق القنوات الصفراء.
قد تؤ ّدي بعض الحاالت إلى إرتفاع نسبة البيليروبين غير المباشر في الدم عن مستوياته الطبيعية  ،كما هو
الحال في اليرقان الفسيولوجي ) ،(neonatal jaundiceعندما ترتفع نسبة البيليروبين في األيام األولى
بعد الوالده مباشرة قبل أن تعود الى مستوياتها الطبيعية .هذا اإلرتفاع الفسيولوجي مهم لحماية خاليا
الجسم ،حيث تعتبر مادة البيليروبين من المواد القوية المضادة لألكسدة واإللتهابات .في المقابل ،هناك
بعض الحاالت الّتي ترتفع فيها نسبة مادة البيليروبين بشكل كبير كما هو الحال مثال في (β-
) ،Thalassemiaحيث يؤدي تكسير كريات ال ّدم الحمراء باستمرار إلى إرتفاع نسبة البيليروبين غير
المباشر ،ومتالزمة ) ،(Crigler Najjar Syndrom Type Iحيث يؤدي غياب االنزيم ((UGT1A1
الى تراكم البيليروبين غير المباشر في ال ّدم .هذا اإلرتفاع الكبير في مادة البيليروبين غير المباشر يحفّز
عملية الموت المبرمج للخاليا ) ،(Apoptosisخاصّة الخاليا العصبيّة حيث يؤ ّدي إلى اليرقان النّووي
والتّلف العقلي )ّ .(Kernicterus
ألن جميع خاليا الجسم ال تحتوي على إنزيم ( (UGT1A1ما عدا خاليا
الكبد ،فإنّها تستخدم وسيلة أخرى للحفاظ على مستويات قليلة من البيليروبين غير المباشر داخلها .هناك
الكثير من الدراسات العلمية والتّجارب العمليّة على الخاليا والنّماذج الحيوانيّة رك ّزت على دور النّقل
النّشط من خالل نواقل ) (MRP1 and MRP3في حماية الخاليا من سميّة مادة البيليروبين غير المباشر.
في هذه الدراسه العلمية قمنا بتحليل التعبير الجيني والبروتيني لهذه النواقل ،بإستخدام (qRT-PCR and
) Western blotفي أنسجة الكبد والطحال ،باعتبارهما األعضاء الرئيسة المسؤولة عن عمليات أيض
البليروبين في النّماذج الحيوانيّة ).(β-Thalassemic mouse and Gunn rat
تشير النتائج إلى ّ
أن التّعبير الجيني والبروتيني للناقل ) (MRP1ال تت ّغير بارتفاع نسبة البيليروبين في الكبد
والطحال ألي من النماذج الحيوانيه المدروسه  ،م ّما يؤ ّشر على ال ّدور المحدود لهذه المض ّخات في حماية
الخاليا من سميّة البيليروبين غير المباشر  ،في المقابل تشير النّتائج إلى أن البيليروبين غير المباشر يؤ ّدي
إلى تحفيزالتّعبير الجيني والبروتيني للناقل ) (MRP3في الكبد للنّموذج الحيواني ) ،(Gunn ratوالطّحال
للنموذج الحيواني ) ، (β-Thalassemic mouseمما يدُل على ال ّدور المهم لهذه المض ّخات في حماية
الخاليا من سميّة البيليروبين غير المباشر.
Introduction:
Bilirubin is the oxidative end product of the heme catabolism. Heme degradation is
performed by the enzyme heme-oxygenase I, producing biliverdin which is then
converted to unconjugated bilirubin (UCB) by the biliverdin reductase. Once
released in the blood and due to its poor aqueous solubility, UCB is tightly but
reversibly binds to albumin and transferred into the liver where it is conjugated
)with glucuronic acid by the enzyme UDP-glucuronosyltransferase 1A1 (UGT1A1
and finally secreted into the bile canaliculus by the MRP2 transporter 1.
2
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UCB has a vital role under physiological and pathological conditions. Neonatal
jaundice is characterised by mild serum UCB level "physiological
hyperbilirubinemia", and the pigment plays an essential cytoprotective role by
acting as a potent antioxidant and anti-inflammatory molecule 2,3. However, when
the plasma level of UCB have excessively elevated the unbound or free fractions
(Bf) of the UCB increase and may cause cell toxicity through different molecular
mechanisms that involved oxidative stress, ER stress, calcium signalling,
inflammation and apoptosis 4,5. UCB elevation is associated with several
conditions such as; low blood pH (acidosis), the use of drugs that compete with
UCB for binding to plasma albumin (e.g., sulfonamide), hyperhemolysis (e.g., βthalassemia), or defect in UGT1A1 activity (e.g., Crigler Najjar syndrome type I)
6,7
.
Unlike hepatocytes, all cells do not possess conjugation activity, and must,
therefore, even oxidise or export UCB to prevent its toxicity. MRPs are family of
ATP-binding cassette transporters (ABC transporters) that mediate the ATPdependent export of many physiological and xenobiotic compounds 8,9, including
UCB 10.
Early studies about a possible role of MRP1 in UCB transport revealed that UCB
at clinically relevant concentration is a substrate for YCF1 and YLL015
(homology to human MRP1 and MRP2, respectively) gene products of transporter
mutants in Saccharomyces cerevisciae11. Pascolo et al. demonstrated that UCB
undergoes ATP-dependent export from trophoblastic BeWo cells by MRP112.
Cultured mouse astrocytes rapidly up-regulated the expression of MRP1 when
exposed to UCB 13. Furthermore, Using Mouse Embryo Fibroblasts (MEF) of
MRP1 knockout mice (-/-) and their wild-type (+/+), Calligaris et al., added more
evidence that MRP1 has a functional role in protecting cells from UCB toxicity 14.
MRP3 share 58% of homology to MRP1 and studies showed it modulation by
conjugated and unconjugated hyperbilirubinemia. Liver MRP3 is up-regulated in
animal models of obstructive cholestasis and when the activity of MRP2 is absent
as a compensatory mechanism in which the conjugated bilirubin and other
substrates are exported from hepatocytes back to the bloodstream for renal
excretion 15,16. In the liver of Gunn rats (the animal model of Crigler Najjar
Syndrom type I), MRP3 is induced in response to high level of UCB 17,18.
In the present study, the expression profile of MRP1 and MRP3 mRNA and
protein was characterised in liver and spleen of two different models of
hyperbilirubinemia; the β-thalassemic mouse with chronic hemolytic
hyperbilirubinemia 19, and the Gunn rat with chronic non-hemolytic
hyperbilirubinemia 20.
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Materials and methods
Animals and serum bilirubin measurement: The study plan was approved by the
Local Committee for Care and Use of Laboratory Animals and all animals were
received human care. Adult WT (C57BL/6J) and β-thalassemic mouse models
(n=5 at six months age) were received from the Department of Clinical and
Experimental Medicines, University of Verona, Italy 19. Seventeen days old (P17)
of Control (NN) and homozygous (jj) Gunn rats were born and raised in the animal
facility of the University of Trieste (n=5)20. Under anaesthesia, animals were
decapitated. The livers and spleens were removed rapidly, rinsed extensively with
ice-cold PBS and then snap-frozen in ice and stored at -80°C. The blood was
collected, and then the total serum bilirubin concentrations were measured by
diazo-reaction (Boehringer–Mannheim Kit 1552414, Monza, Italy).
Total RNA extraction and quantification: Total RNA was isolated from tissues
using the TRI Reagent (Sigma, USA) following the manufacturer’s instructions.
RNA concentration was obtained spectrophotometrically (Beckman Coulter,
DU®730) from A260 measurements (A260/A280 ratio was between 1.7 and 2.1).
The integrity of the sample was assessed with 1% agarose gel electrophoresis.
Reverse Transcriptase and quantitative real-time PCR: The cDNA was obtained
from 1µg of purified MMLV-derived reverse transcriptase system kit (iScript
™cDNA Synthesis Kit, BioRad Laboratories, Hercules, CA, USA) following the
manufacturer’s instructions. Reverse transcriptase was performed in a thermal
cycler at 25 °C for 5 min, 45 °C for 30 min, and 85 °C for 5 min. cDNA was stored
at -20 C. Real-Time quantitative PCR was performed with an iCycler IQ (BioRad
Laboratories, Hercules, CA, USA).18S and GAPDH were used as an endogenous
control to normalise the expression level of target genes. The primers were
designed by using the software Beacon Designer 2.0 (PREMIER Biosoft
International, Palo Alto, CA, USA). Primers used were listed in (Table 1).
cDNA (25 ng) was amplified by PCR using primers for selected genes in separate
wells with 1x iQ SYBR Green Supermix and 250nM gene-specific sense and
antisense primers in a final volume of 25 µl for each well. The used iQ SYBR
Green Supermix comprises of 100mM KCl, 40mM Tris–HCl, pH 8.4, 0.4mM each
dNTP, 50 U/ml iTaq DNA polymerase, 6mM MgCl2, SYBR Green I, 20nM
fluorescein, and stabilizers. The PCR was performed in 96-well plates, each
sample was performed in triplicate, and a no-template control was included for
each amplification as a negative control. The thermal cycler conditions consisted
of 3 min at 95 °C and 40 cycles at 95 °C for 20 s, 60 °C for 20 s and 72 °C for 30
s. In order to verify the specificity of the amplification, a melt-curve analysis was
performed for; 1 min denaturation at 95 °C, 1 min annealing at 55 °C, and 80
cycles of 0.5 °C increments (10 s each) beginning at 55 °C. Thel melt-curve
https://digitalcommons.aaru.edu.jo/hujr_a/vol8/iss1/1
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analysis was carried out immediately after the amplification protocol. Non-specific
products of PCR were not found in any case. A standard curve was generated using
a “calibrator” cDNA (chosen among the cDNA samples), which was serially
diluted and analysed. The iCycle iQ Real-Time PCR Detection System Software
generated the equation describing the plots of the log10 of the starting quantity
(micromoles) of 5 dilutions (125, 25, 5, 1, and 0.2 ng) of the calibrator cDNA
versus the corresponding threshold cycle. The efficiency of qRT-PCR of primer
pairs was calculated with the following formula:
Efficiency = [10 (-1/slope)] – 1
To reduce the experimental variation, the results were normalised to 18S and
GAPDH. The initial amount of the template of each sample was determined as
relative expression versus one of the samples chosen as a reference (in this case the
control sample) which is considered the 1x sample. Data were analysed using the
Gene Expression analysis for iCycler V1.10 2004 (Bio-Rad). Briefly, for each set
of replicates, the spreadsheet calculates the mean Ct and the standard deviation for
the sample and derives a relative quantity from the equation:
Relative quantity = efficiency (control Ct – unknown Ct)
Where the control Ct is the Ct of a sample chosen as a control, and the unknown Ct
is the value of the sample of interest. The normalisation factor is calculated as the
geometric mean of the relative quantities for all reference genes use:
Normalization factor = (quant. ref.1* quant.ref.2*…* quant. ref.N) (1/N)
The unscaled expression level for the sample of interest is calculated using the
equation:
Expression level = relative quantity/normalization factor
Then a scaled value dividing the unscaled expression level of each sample by the
unscaled expression level of the control sample is calculated.
Protein extraction, quantification and SDS-PAGE: Liver and spleen tissues (50
µg) were thawed and homogenised with 150µl of 10mM HEPES (pH 7.4),
containing 0.2mM CaCl2 and 0.25M sucrose, using a tight Dounce–Potter device.
Protein concentration was assessed spectrophotometrically with the bicinchoninic
acid reaction with bovine serum albumin as standard 21.
SDS–PAGE separated proteins homogenate containing loading dye with 10% ßmercaptoethanol in 10% acrylamide gel. Molecular weight standards 53-212 kDa
(Amersham–Pharmacia, Buckinghamshire, UK) were used as marker proteins. The
gel was run by electrophoresis as follow: 80V for stacking region and 180Vfor
running region. Then, the gel was obtained and blotted onto a nitrocellulose
membrane (PVDF) (Schleicher and Schuell, Dassel, Germany) with a wet blotting
system (Sigma, St. Louis, MO, USA), using transfer solutions (700ml H2O, 200ml
methanol 20%, and 100 ml transfer solution 10X) for 2 hour at 100V. After
Published by Arab Journals Platform, 2019
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transfer, the gel was checked by Coomassie blue and the PVDF membrane by red
Ponceau. The membrane was washed three times with T-TBS (0.2% Tween 20;
20mM Tris; and 500mM NaCl; pH 7.5) and blocked with the 4% milkT-TBS
solution for 1 hour at room temperature. The primary antibodies were diluted with
the same blocking solution and incubated overnight at 4°C (1:2000 dilution). Next
day the primary antibodies were removed, the membrane was washed and
incubated with secondary antibodies for 1 hour at room temperature (1:5000
dilution). The peroxidase reaction was obtained by exposure of the membrane in
the ECL-Plus Western Blotting detection system solutions (Amersham–
PharmaciaBiotech, UK). After transfer to Kodak film, the bands were visualised by
Kodak EDAS 290 (Kodak instruments, New Haven, Ct, USA) using Kodak 1D
images software. The images were taken in TIFF formats and transferred to the
Scion Image program. The optical density of the target proteins was taken and
normalised to α-actin and represented as protein relative expression (ratio). List of
antibodies and conditions of incubation were summarised in (Table 2).
Statistical analysis: Data are reported as means ± SD. The two-tailed Student “ttest assessed differences between means”. The values considered significant when
p<0.05 *, p<0.01 ** and p<0.001 ***.
Results
Total serum bilirubin levels in β-thalassemic mouse and Gunn rat
TSB level was markedly elevated (6 folds) in β-thalassemic mouse compared to
WT mouse, and in 17 days old jj Gunn rat (14 folds) compared to NN control rat
(Table 3).
MRP1 expression in the spleen of β-thalassemic mouse and liver of Gunn rat
Spleenic MRP1 mRNA and protein expression were expressed equally in both WT
and β-thalassemic mice (Figure 1A and 1B). Similarly, hepatic MRP1 mRNA and
protein expression were not changed in jj Gunn rat compared to NN control rat at
17 days old (Figure 2A and 1B).
MRP3 expression in the spleen of β-thalassemic mouse and liver of Gunn rat
Spleenic MRP3 mRNA expression was up-regulated (5.5 folds) in ß-thalassemic
mouse compared to WT mouse. MRP3 protein was undetectable in WT mouse
while 100% induced in β-thalassemic mouse (Figure 3A and 3B). The C-18
antibodies recognise the two bands for MRP3 protein (Figure 3A), which is
probably the differentially glycosylated forms that were recognised by different
antibodies used in the previous study 22. Hepatic MRP3 mRNA and proteins were
induced (3 folds and 2.5 folds, respectively) in jj Gunn rat than NN control rat 17
days old (Figure 4A and 4B).

https://digitalcommons.aaru.edu.jo/hujr_a/vol8/iss1/1

6

Qaisiya and Bellarosa: Analysis of MRP1 and MRP3 expression profile in liver and spleen
Mohammad Qaisiya, Cristina Bellarosa, Analysis of MRP1 and MRP3…, H.U.R.J, Vol. (8), 2019

7

Discussion and conclusion
Unconjugated bilirubin (UCB) is responsible for neonatal jaundice and at this
physiological condition UCB has significant cytoprotective roles. UCB
accumulates in organs and causes cytotoxicity especially for neurons due to high
blood concentration6. Because UCB can diffuse into any cell type, all cells must
maintain low intracellular concentration; this is regulated by consumption
(conjugation and oxidation) and/or export of the UCB back to blood serum10. The
liver is the only organ that can conjugate UCB by the UGT1A1 enzyme and
therefore other cell types should oxidise or export UCB to prevent its toxicity.
Previous studies focused on the possible role for MRP1 and MRP3 in exporting
UCB out of the cells to prevent its intracellular toxicity. In vitro studies suggested
that MRP1 might have a crucial role in protecting cells against UCB toxicity 11–14.
However, many of the published in vitro findings may be irrelevant to the in vivo
condition 23. Many factors may affect the in vitro studies such as the type of cell,
species differences in the cellular systems employed, the length of exposure to
UCB and cell age in culture. Several studies using in vivo and in vitro models also
demonstrated an essential role for MRP3 in transporting UCB back to the
bloodstream for renal excretion 15,16,24.
In the present work, the mRNA and protein expression profile for MRP1 and
MRP3 were analysed in vivo under two different conditions of hyperbilirubinemia
which was confirmed by measuring the TSB levels (Table 3). Expression of both
transporters was analysed in the spleen of the β-thalassemic mouse (chronic
hemolysis - conjugated hyperbilirubinemia) and liver of Gunn rat (UGT1A1
deficiency – unconjugated hyperbilirubinemia) because each organ (with its related
animal model) is exposed to high level of UCB.
In the spleen of the β-thalassemic mouse, qRT-PCR data and Western blot analysis
indicated that UCB did not change the mRNA and protein expression of MRP1,
while it induced the MRP3 mRNA expression (Figure 1 and 3). Similarly, in the
liver of Gunn rat, MRP1 mRNA and protein expression were not changed, while
MRP3 mRNA and protein levels were induced by UCB (Figure 2 and 4).
The results obtained in both animal models showed that any form of
hyperbilirubinemia does not modulate MRP1expression in vivo. Analysis of MRP1
promoter constructs indicated that the promoter is TATA-less, CAAT-less and the
GC rich may form the CpG island and suggested that MRP1 has a heavy promoter
that makes this gene hardly to be induced under several conditions25,26.
Furthermore, we cannot exclude any role for MRP1 (if any) in transporting UCB
because the basal expression could be enough for its maximum transporting
activity. Indeed, the mRNA basal expression for MRP1 is much higher than MRP3
in both tissues (data not shown).
Published by Arab Journals Platform, 2019
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The results also indicated that UCB induced the mRNA and protein expression of
MRP3 transporter and suggested its possible role in exporting UCB back to the
bloodstream. The induction of MRP3 by UCB seems to be at transcriptional level.
Indeed, MRP3 gene was suggested to be an inducible form among MRPs family,
and it has a promoter construct with TATA-box, CAAT-box, and has several
enhancer cis-elements 27,28.
In conclusion, our in vivo study showed that the high level of UCB did not change
MRP1 expression in the spleen of β-thalassemic mouse and liver of Gunn rat.
MRP3 is induced in both organs exposed to high level of UCB. More in vitro
experiments should be performed to analyse the direct role of MRP3 in preventing
UCB toxicity
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List of Tables
Table 1. Primer sequences of genes designed for quantitative real time-PCR
Gene
Name

Accession
number

Forward primers 5` - 3.` 5'
to 3.'

Reverse primers 5` - 3.` 5' to 3.'

MRP1

NM_008576.

CGTGCTGTCCTGCTTCTC

CTTCTGATGTGTCCTCCTTATTC

MRP3

NM_029600

GGTTATCCAGGCTCAAGAC

GCCGTGGAAGGAATAGAAC

18S*

NR_003278.

TCCGATAACGAACGAGAC

CTAAGGGCATCACAGACC

GAPDH*

NM_008084.

CCAGTATGACTCCACTCACG

CTCGCTCCTGGAAGATGGTG

*Housekeeping genes used to normalise the expression of target genes.

Target
proteins
MRP1
MRP3
α-actin*

Table 2. Summary of antibodies
1 antibodies
2nd antibodies
st

A23 (Fernetti et al.,) 2001)
C18(Santa Cruz Biotech)
A2066 (Sigma Aldrich)

Goat anti-rabbit IgG/HRP (Dacko Lab.)
Donkey anti-goat IgG/HRP (Jackson Lab.)
Goat anti-rabbit IgG/HRP (Dacko Lab.)

*Housekeeping protein used to normalise the expression of target proteins.

Table 3: Total serum bilirubin (TSB) in WT and hyperbilirubinemic animal
models
Animal
Total serum bilirubin (TSB) mg/dl
model
1.6.±.0.53
WT mouse
5.95 ± 0.75
β-Thal mouse
0.33 ± 0.1
NN WT rat
13.83 ± 3.33
jj Gunn rat
TSB was measured by diazo-reaction in five animals for each group

https://digitalcommons.aaru.edu.jo/hujr_a/vol8/iss1/1

12

Qaisiya and Bellarosa: Analysis of MRP1 and MRP3 expression profile in liver and spleen
13

Mohammad Qaisiya, Cristina Bellarosa, Analysis of MRP1 and MRP3…, H.U.R.J, Vol. (8), 2019

List of Figures
A)

B)
Mrp1 mRNA Rel. Exp

2
WT

β-Thal

1.5
Mrp1 (170KDa)
1

Ratio
α-actin (43KDa)

0.5

1

0.8

0.8

0.7

0

WT

β-Thal

Spleen

Figure 1: (A) MRP1 mRNA relative expression in the spleen of WT and βthalassemic mouse. MRP1 expression was normalised to 18S and GAPDH and
presented relative to WT controls. (B) MRP1 protein expression was analysed by
western blot and normalised to α-actin then represented as a ratio.
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Figure 2: (A) MRP1 mRNA relative expression in liver of NN control rat and jj
Gunn rat. MRP1 expression was normalised to 18S and GAPDH and presented
relative to NN controls. (B) MRP1 protein expression was analysed by western
blot and normalised to α-actin then represented as a ratio.
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Figure 3: (A) MRP3 mRNA relative expression in the spleen of WT and βthalassemic mouse. MRP1 expression was normalised to 18S and GAPDH and
presented relative to WT controls. (B) MRP3 protein expression was analysed by
western blot and normalised to α-actin then represented as a ratio.
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Figure 4: (A) MRP3 mRNA relative expression in liver of NN control rat and jj
Gunn rat. MRP1 expression was normalised to 18S and GAPDH and presented
relative to NN controls. (B) MRP3 protein expression was analysed by western
blot and normalised to α-actin then represented as a ratio.
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